Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Sham-procedure-controlled, Blinded Study to Evaluate the Effectiveness and Acceptability of Right-sided Stellate Ganglion Block for Treatment of Posttraumatic Stress Disorder Symptoms

NCT03077919 is registered in ClinicalTrials.gov with RTI International as lead sponsor.

NCT NCT03077919
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03077919 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Sham-procedure-controlled, Blinded Study to Evaluate the Effectiveness and Acceptability of Right-sided Stellate Ganglion Block for Treatment of Posttraumatic Stress Disorder Symptoms
Lead sponsor
RTI International
Phase
Not applicable
Overall status
Completed
Start date
May 25, 2016
Completion date
June 9, 2018
Enrollment
113 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

posttraumatic stress disorder